The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
Authors
Keywords
-
Journal
MALARIA JOURNAL
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-08
DOI
10.1186/s12936-019-2989-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malaria vaccines in the eradication era: current status and future perspectives
- (2019) K Wilson et al. Expert Review of Vaccines
- Identification of domains within Pfs230 that elicit transmission blocking antibody responses
- (2019) Mayumi Tachibana et al. VACCINE
- Transmission-Blocking Vaccines: Old Friends and New Prospects
- (2019) Festus K. Acquah et al. INFECTION AND IMMUNITY
- Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate
- (2019) Shwu-Maan Lee et al. PROTEIN EXPRESSION AND PURIFICATION
- Secretory expression and scale-up production of recombinant human thyroid peroxidase via baculovirus/insect cell system in a wave-type bioreactor
- (2018) Ying Lou et al. PROTEIN EXPRESSION AND PURIFICATION
- Progress toward a transmission-blocking vaccine against malaria
- (2018) Tomoko Ishino et al. LANCET INFECTIOUS DISEASES
- Antimalarial Transmission-Blocking Interventions: Past, Present, and Future
- (2018) M.J. Delves et al. TRENDS IN PARASITOLOGY
- Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A
- (2018) Martin Burkhardt et al. VACCINE
- Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
- (2018) Florian Brod et al. Frontiers in Immunology
- HPV vaccines – A review of the first decade
- (2017) Diane M. Harper et al. GYNECOLOGIC ONCOLOGY
- Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity
- (2017) Puthupparampil V. Scaria et al. PLoS One
- Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium
- (2017) Camila Henriques Coelho et al. npj Vaccines
- Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230
- (2016) Nicholas J. MacDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
- (2016) Shwu-Maan Lee et al. MALARIA JOURNAL
- Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
- (2016) Kazutoyo Miura et al. VACCINE
- Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays
- (2013) Kazutoyo Miura et al. PLoS One
- Recombinant protein vaccines produced in insect cells
- (2012) Manon M.J. Cox VACCINE
- N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity
- (2011) Mayumi Tachibana et al. Clinical and Vaccine Immunology
- A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum
- (2011) Christine E. Farrance et al. Clinical and Vaccine Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started